Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Corporate Governance > Insider Transactions

Insider TransactionsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Date Name Title Type Shares Traded Price Range
Apr 17, 2014 turgeon joseph w. Officer Acquisition (Non Open Market) 120,000 n/a
Mar 25, 2014 allen lee f md phd Officer Acquisition (Non Open Market) 8,000 n/a
Mar 25, 2014 gustafson kurt a Officer Acquisition (Non Open Market) 15,000 n/a
Jan 3, 2014 shrotriya rajesh c md Officer Disposition (Non Open Market) 17,715 8.79
Dec 19, 2013 shrotriya rajesh c md Officer Disposition (Non Open Market) 17,110 8.24
Dec 13, 2013 cohen raymond w Director Acquisition (Non Open Market) 10,000 n/a
Dec 13, 2013 gagnon gilles Director Acquisition (Non Open Market) 10,000 n/a
Dec 13, 2013 krassner stuart mitchell Director Acquisition (Non Open Market) 10,000 n/a
Dec 13, 2013 lenaz luigi md Director Acquisition (Non Open Market) 10,000 n/a
Dec 13, 2013 maida anthony e iii Director Acquisition (Non Open Market) 10,000 n/a
Dec 13, 2013 shrotriya rajesh c md Officer Acquisition (Non Open Market) 80,000 n/a
Dec 13, 2013 vyas dolatrai Director Acquisition (Non Open Market) 10,000 n/a
Dec 3, 2013 keller joseph kenneth Officer Acquisition (Non Open Market) 30,000 n/a
Dec 3, 2013 turgeon joseph w. Officer Acquisition (Non Open Market) 25,000 n/a
Nov 29, 2013 shrotriya rajesh c md Officer Disposition (Non Open Market) 62,925 9.59
Sep 4, 2013 shrotriya rajesh c md Officer Option Execute 403,948 1.99 - 4.90
Jun 3, 2013 gustafson kurt a Officer Acquisition (Non Open Market) 100,000 n/a
Apr 20, 2013 allen lee f md phd Officer Statement of Ownership 0 n/a
Apr 20, 2013 turgeon joseph w. Officer Statement of Ownership 0 n/a
Mar 5, 2013 maida anthony e iii Director Automatic Sell 5,000 11.50
Showing 1-20 of 141 transactions Page: 1 2 3 4 5 6 7 8  See Next 20

Stock transaction information provided by EDGAR Online. Spectrum Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPISpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Price:
6.65
Change:
- 0.09
Day High:
6.77
Day Low:
6.62
Volume:
139,700
10:26 AM ET on Apr 21, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder ToolsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Print Email

Search IRSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company